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The mitogenicity and lethal toxicity of chemically synthesized lipid A analogs, in which 2,3-acyloxyacylglucosamine-4- 
phosphate linked to tetraacetyl-N-acetylneuraminic acid (compound A-207) or to N-acetylneuraminic acid (compound 
A-307), were examined. Although the mitogenic activity of the synthetic compounds was weaker than that of bacterial 
LPS, doses of 1650 fig/ml of A-207 and >I0 pg/ml of A-307 were capable of increasing incorporation of PH]thymidine 
into cultured spleen cells of C57BL/6 mice. Lethal toxicity of A-207 was observed at 10 fig/mouse in C57BL/6 mice sensi- 
tized with D-galactosamine hydrochloride. However, the attachment of tetraacetyl-IV-acetylneuraminic acid or N-acetyl- 
neuraminic acid does not appear to enhance the biological activity of acyloxyacylglucosamine-4-phosphate. 
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1. INTRODUCTION 
Lipid A of bacterial lipopolysaccharide (LPS) is 
well known to possess many biological activities 
[ 11. Recently, various derivatives of acyloxyacyl- 
glycosamine-4-phosphate as monosaccharide ana- 
logs of lipid A have been synthesized, and these 
compounds as well as synthetic glucosamine disac- 
charide analogs of lipid A [2-51 induced the pro- 
duction of interferon and tumor necrosis factor, 
and secretioq of interleukin I, and exhibited 
mitogenic activity for B-lymphocytes, antitumor 
activity, and lethal toxicity, etc. [6-131. 
There are many reports that gangliosides play 
roles in immune responses [14]. N-Acetyl- 
neuraminic acid-containing gangliosides were 
found to inhibit the LPS-induced activation of 
murine B-lymphocytes [ 151. The biological ac- 
tivities of monosaccharide analogs of lipid A N- 
acetylneuraminic acid are therefore of interest. 
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Here, we examined the mitogenicity and lethal 
toxicity of chemically synthesized acyloxyacyl- 
glucosamine-4-phosphate (Acyl-GlcN-4-P) linked 
to tetraacetyl-N-acetylneuraminic acid (AQ- 
NeuAc, compound A-207) or N-acetylneuraminic 
acid (NeuAc, compound A-307). 
2. MATERIALS AND METHODS 
The compounds tested in this study, A-207 and A-307, were 
synthesized as described in (161; their chemical structures are 
shown in fig.1. Before experiments, each compound was 
suspended in pyrogen-free saline supplemented with 0.1 Vo 
triethylamine (v/v) and sonicated for 20-30 s. Reference LPS 
was isolated from dried cells of Salmonella typhimurium LT-2 
by the hot phenol-water method [17] and purified by ultracen- 
trifugation (105000 x g, 1 h). 
Mitogenicity was tested using spleen cells of C57BL/6 mice. 
The splenocytes were suspended in RPMI-1640 medium sup- 
plemented with 10% fetal bovine serum. 0.1 ml (5 x lo5 cells) 
of the cell suspension and 0.1 ml of a suspension of a test com- 
pound or reference material were placed in a 96-well 
microplate. The plate was incubated at 37°C for 64 h in an at- 
mosphere of 5% CO2/95% air. After addition of 0.25 pCi 
[‘Hlthymidine to each well, the plate was further cultivated for 
16 h. Splenocytes were harvested with an automatic cell 
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Fig. 1. Structure of synthetic lipid A analogs linked to N- 
acetylneuraminic acid. AC, acetyl; CWO-Cl4 (R)-3-tetra- 
decanoyloxy-tetradecanoyl. 
Compounds R’ (N-) RZ (3-O-) R 
A-207 c,4-o-(C14) CWo-(C14) AC 
A-307 c,I-o-(cII) CWo-(Cl.%) H 
harvester. Radioactivity taken up by the cells was measured 
with a liquid scintillation counter. Results were expressed as 
mean cpm. 
Lethal toxicity was tested according to Galanos et al. [18]. In 
brief, groups of C57BL/6 mice were sensitized by in- 
traperitoneal injection of 640 mg/kg of D-galactosamine 
hydrochloride in 0.5 ml saline, followed immediately by in- 
travenous injection of a test compound in 0.2 ml saline. The 
mice were observed over a 24 h period, and the number of 
deaths recorded. 
3. RESULTS AND DISCUSSION 
The results of the mitogenic assay of A-207 and 
A-307 are listed in table 1. Compound A-207 ex- 
hibited slight mitogenic activity at a dose of 10 
rg/ml or more. On the other hand, the mitogenic 
activity of A-307 was also observed at doses of 5 
and lOpg/ml but seemed to be weaker than that of 
A-207. However, the attachment of Ac4-NeuAc or 
NeuAc does not appear to enhance the activity of 
acyl-Glen-4-P. 
Previously, we reported that the mitogenic ac- 
tivity of acyl-GlcN-4-P linked to tetra-acetyl-3- 
deoxy-D-manno-2-octulosonic acid (Acd-KDO) 
was stronger than that of the original acyl- 
GlcN-4-P derivatives [ 191. There are some struc- 
tural similarities between iV-acetylneuraminic acid 
and KDO, since they have a ketosidic linkage and 
an acidic group in the pyranosyl skeleton. An ex- 
planation for the difference in mitogenic activities 
between the derivatives of Ac4-NeuAc and 
Acd-KDO awaits discovery. 
Table 1 
Mitogenic activity of synthetic lipid A analogs 
Preparations Dose [3H]TdR uptake S.1. 
&g/ml) (cpm * SD) 
Expt 1 
A-207 50 3682 + 860 2.2” 
25 3791 f 524 2.3” 
10 2968 + 470 lJa 
1 2556 * 173 1.5” 
0.5 2323 + 34 1.4 
S. typhimurium LT-2 
LPS 10 13090 + 4080 7.8 
Control (no addition) 1668 f 379 1.0 
Expt 2 
A-307 50 2069 + 44 0.9 
25 2669 t 65 1.2 
10 3795 + 58 1.7” 
5 3 829 + 249 1.7” 
1 3277 + 115 1.4 
S. iyphimurium LT-2 
LPS 10 30680 + 2269 13.3 
Control (no addition) 2311 * 143 1.0 
a P<O.OS 
S.I. (stimulation index) = experimental cpm/control cpm 
LPS of S. typhimurium LT-2 showed lethal tox- 
icity within 6-8 h after treatment at doses of 0.1 
and 1 .O /rg/mouse (table 2). Compound A-207 was 
toxic to 3 out of 4 mice at a dose of lOpg/mouse, 
and all mice were dead at doses of 25 and 50 
fig/mouse. The lethal toxicity of A-207 is con- 
sidered to be almost the same as that of Ac4-NeuAc 
free compounds [9, lo]. 
A-207 could not induce the local Shwartzman 
reaction at doses of 40 and 80pg/site in rabbit (not 
shown). From this finding and other results [2-S], 
it is assumed that the induction of the Shwartzman 
reaction requires the presence of glucosamine 
disaccharide in lipid A. 
This is the first report on the mitogenic activity 
Table 2 
Lethal toxicity of synthetic lipid A analog (A-207) in 
galactosamine-sensitized C57BL/6 mice 
Preparations No. of deaths/no. of mice 
tested at indicated dose kg) 
0.1 1.0 5 10 25 50 
A-207 ND” O/4 O/4 3/4 4/4 414 
S. typhimurium LT-2 LPS 3/3 4/4 ND ND ND ND 
“ND, not done 
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and lethal toxicity of acyl-GlcN-4-P linked to N- 
acetylneuraminic acid or tetraacetyl-N-acetyl- 
neuraminic acid. Our results indicate that the at- 
tachment of N-acetylneuraminic acid does not 
enhance the biological activities of acyl-GlcN-4-P. 
However, the possibility that the compounds may 
exhibit some biological activities in other ex- 
periments cannot be ruled out. Further chemical 
modification of lipid A analogs may yield new 
biological response modifiers. 
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